SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875320-19-000026
Filing Date
2019-07-25
Accepted
2019-07-25 16:45:11
Documents
4
Period of Report
2019-07-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxceoannouncement.htm 8-K 36871
2 EXHIBIT 10.1 executiveemploymentagreeme.htm EX-10.1 89001
3 EXHIBIT 10.2 changeofcontrol-rk1.htm EX-10.2 52167
4 EXHIBIT 10.3 amendmentno1.htm EX-10.3 109483
  Complete submission text file 0000875320-19-000026.txt   288657
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 19974964
SIC: 2834 Pharmaceutical Preparations